Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Burning Rock Biotech (BNR) Non Operating Income: 2021-2024

  • Burning Rock Biotech's Non Operating Income rose 332.42% to $595,000 in Q4 2024 from the same period last year, while for Dec 2024 it was -$120,000, marking a year-over-year increase of 73.57%. This contributed to the annual value of $645,000 for FY2024, which is 848.53% up from last year.
  • According to the latest figures from Q4 2024, Burning Rock Biotech's Non Operating Income is $595,000, which was up 297.02% from -$302,000 recorded in Q3 2024.
  • Over the past 5 years, Burning Rock Biotech's Non Operating Income peaked at $595,000 during Q4 2024, and registered a low of -$302,000 during Q3 2024.
  • Moreover, its 3-year median value for Non Operating Income was -$185,500 (2022), whereas its average is -$26,833.
  • Examining YoY changes over the last 5 years, Burning Rock Biotech's Non Operating Income showed a top increase of 5,495.78% in 2022 and a maximum decrease of 267.80% in 2022.
  • Over the past 4 years, Burning Rock Biotech's Non Operating Income (Quarterly) stood at -$58,184 in 2021, then slumped by 267.80% to -$214,000 in 2022, then decreased by 19.63% to -$256,000 in 2023, then soared by 332.42% to $595,000 in 2024.
  • Its last three reported values are $595,000 in Q4 2024, -$302,000 for Q3 2024, and -$256,000 during Q4 2023.